EIF3I and hepatocellular carcinoma: Previous studies demonstrated that the overexpression of eIF3I interacted with and activated the oncogenic Akt1 by preventing the PP2A-mediated dephosphorylation of Akt-1 in human hepatocellular carcinoma [24].